Release Date: 02/09/16 14:45 Summary: Trading Halt-KDR.AX Price Sensitive: Yes Download Document 566.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%